Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
20,268 | Dovepress* | 17,197+ | 1,747 | 18,944 | |
PubMed Central* | 3,071 | 730 | 3,801 | ||
Totals | 20,268 | 2,477 | 22,745 | ||
*Since 21 August 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
7 | 0 | 0 | 0 | 1 | 6 |
View citations on PubMed Central and Google Scholar